XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 235,103 $ 233,121
Short-term investments 14,826 73,694
Accounts receivable, net 1,665 909
Notes receivable, net 3 1,514
Inventory 9,508 8,737
Prepaid expenses and other current assets 8,844 5,202
Total current assets 269,949 323,177
Property and equipment, net 151,024 166,471
Customer relationship intangibles and other intangibles, net 38,774 42,168
Operating lease, right-of-use assets 14,333 15,290
Goodwill 12,217 12,098
Other assets, non-current 2,691 5,100
Total assets 488,988 564,304
Current liabilities:    
Accounts payable 19,431 21,251
Accrued expenses 16,530 13,976
Accrued compensation 8,856 10,731
Short-term debt 10,989 5,917
Deferred revenue 7,007 6,708
Other liabilities 5,090 2,435
Total current liabilities 67,903 61,018
Long-term debt, net 168,500 169,099
Warrant liability 55,440 42,900
Operating lease liabilities, non-current 14,182 15,594
Deferred revenue, non-current 3,774 3,774
Deferred tax liability 6,115 10,803
Other liabilities, non-current 11 13
Total liabilities 315,925 303,201
Commitments and Contingencies (Note 9)
Stockholders’ equity:    
Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of $175,302,694 and $167,392,315 as of June 30, 2024 and December 31, 2023, respectively 18 17
Additional paid-in-capital 931,363 857,037
Accumulated other comprehensive gain (loss) 15 (62)
Accumulated deficit (761,085) (598,845)
Total Enovix's stockholders’ equity 170,311 258,147
Non-controlling interest 2,752 2,956
Total equity 173,063 261,103
Total liabilities and equity $ 488,988 $ 564,304